Rol de la matrona en crisis hipertensivas
Cargado por
franciscabarrientos83Rol de la matrona en crisis hipertensivas
Cargado por
franciscabarrientos83Common questions
Con tecnología de IAThe primary treatment options for hypertensive crises in pregnancy include Labetalol, Nifedipine, and Hydralazine. Labetalol can be administered via IV boluses starting at 20 mg every 20 minutes, increasing to a maximum of 300 mg, or through continuous infusion starting at 0.5 mg/min and potentially increasing to 4 mg/min . Nifedipine is administered orally or sublingually at 10-20 mg every 20-30 minutes with an onset of action within 10-15 minutes . Hydralazine is given intravenously at 20-40 mg in 500 ml glucose solution and can be divided into 5 mg doses repeated every 20 minutes if the diastolic blood pressure is over 110 mmHg .
Corticosteroids are integrated into the management of hypertensive crises in pregnancy primarily to enhance fetal lung maturity when the gestational age is less than 34 weeks and the risk of preterm delivery due to severe hypertensive crises is high . This intervention is crucial for reducing neonatal respiratory complications. When a crisis is persistent or severe before 34 weeks, corticosteroids are administered along with the consideration of interrupting the pregnancy to safeguard maternal and fetal health . These drugs support better management of delivery timing, especially when balancing the risks and benefits of continuing the pregnancy against potential preterm birth complications .
Hydralazine is indicated for use in hypertensive crises in pregnancy when there is a need for rapid reduction of blood pressure, particularly in severe cases where other treatments may be contraindicated or ineffective . It is administered intravenously at dosages of 5 mg every 20 minutes if the diastolic blood pressure remains above 110 mmHg, or it can be delivered through a continuous infusion in a diluted glucose solution . This approach allows for careful titration of the drug to achieve desired blood pressure control while minimizing adverse effects .
Pregnancy should be considered for interruption in cases of persistent hypertensive crises, particularly if there are more than three episodes or deterioration of maternal or fetal condition . Certain criteria for severity also warrant interruption, such as the presence of pre-eclampsia with severe features, or when the gestational age is between 34-35 weeks accompanied by pre-eclampsia and hypertensive crisis . If the pregnancy is under 34 weeks, corticoids may be administered, and the pregnancy interrupted if the hypertensive crisis is persistent or severe .
Long-term management of hypertension in pregnancy after a hypertensive crisis involves maintaining blood pressure within target ranges using oral antihypertensives like Methyldopa, which is administered at 250 mg every 12 hours or 500 mg every 6 hours . Continuous monitoring and adjustment of medication based on blood pressure response are critical. Follow-up examinations and lifestyle modifications like dietary changes are also recommended to minimize risks of subsequent episodes . Regular check-ups and collaborated care between obstetricians and internal medicine specialists help in better management strategies .
Healthcare professionals, including midwives, are crucial in managing hypertensive crises during pre-labor by conducting continuous monitoring of the patient’s vital signs, administering prescribed antihypertensives, and informing medical staff immediately in case of severe symptoms . Midwives ensure the timely administration of medications like magnesium sulfate for seizure prevention and collaborate closely with physicians to decide if the pregnancy should be interrupted . They also perform routine checks for symptoms of severity, such as persistent high blood pressure, and maintain records of fluid balance to guide treatment decisions .
The management of hypertensive crisis in pregnancy is tailored based on symptoms and the patient's condition. Continuous monitoring of vital signs is essential, with interventions like antihypertensive medications and furosemide for pulmonary edema . If severe symptoms are observed, like severe headaches or sustained hypertension, intravenous medications such as Labetalol or Hydralazine are preferred . If the patient is at a high risk of complications, such as those with pre-eclampsia, supplementary interventions like magnesium sulfate for seizure prophylaxis may be administered .
Magnesium sulfate is recommended for seizure prophylaxis in severe hypertension during pregnancy, particularly in cases of pre-eclampsia, due to its neuroprotective effects and its ability to stabilize neuronal membranes, reducing the risk of seizures . It helps in managing severe pre-eclampsia by lowering the excitability of neurons which could potentially trigger seizures . Protocols include a loading dose followed by continuous maintenance to ensure therapeutic concentrations are achieved and maintained . This approach significantly reduces the incidence of eclampsia, enhancing maternal and fetal outcomes .
A Foley catheter is utilized in managing hypertensive crises in pregnancy to ensure accurate monitoring of urine output, which is crucial for assessing renal function and fluid balance . Accurate measurement of urine output helps clinicians evaluate the effectiveness of diuretic therapies and fluid management strategies, essential for patients at risk of pulmonary edema or other complications due to fluid overload . Placing a Foley catheter also allows for better application of evidence-based management protocols by providing precise data critical for treatment adjustments and patient care .
Labetalol and Nifedipine are both used to treat hypertensive crises during pregnancy but have distinct characteristics and indications. Labetalol, administered intravenously or orally, is preferred when rapid blood pressure control is needed; however, it is contraindicated in patients with heart failure, bronchial asthma, or AV block . Nifedipine, administered orally or sublingually, acts quickly as well, within 10-15 minutes, and is contraindicated in patients with a high risk of coronary artery disease or hypertensive encephalopathy . Labetalol is typically delivered in an acute care setting with continuous monitoring, whereas Nifedipine can be administered under less intense supervision but still requires careful observation for adverse effects .